Development of Basal Cell Carcinoma With Squamous Differentiation During Vismodegib Treatment

Dermatol Surg. 2017 Jul;43(7):989-991. doi: 10.1097/DSS.0000000000001012.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Administration, Oral
  • Aged, 80 and over
  • Anilides / administration & dosage
  • Anilides / therapeutic use*
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Basal Cell / drug therapy*
  • Carcinoma, Basal Cell / pathology*
  • Cell Differentiation
  • Drug Resistance, Neoplasm
  • Facial Neoplasms / drug therapy*
  • Facial Neoplasms / pathology*
  • Female
  • Humans
  • Mohs Surgery
  • Nose Neoplasms / pathology*
  • Nose Neoplasms / surgery
  • Pyridines / administration & dosage
  • Pyridines / therapeutic use*
  • Surgical Flaps

Substances

  • Anilides
  • Antineoplastic Agents
  • HhAntag691
  • Pyridines